Profile | GDS4284 / 200914_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 14125.9 | 98 |
GSM687648 | Patient 402 control | 9167.8 | 97 |
GSM687653 | Patient 403 control | 10061.3 | 97 |
GSM687658 | Patient 404 control | 14110.6 | 98 |
GSM687663 | Patient 411 control | 10271.9 | 97 |
GSM687668 | Patient 422 control | 9673.55 | 97 |
GSM687673 | Patient 424 control | 10441.4 | 97 |
GSM687678 | Patient 425 control | 10369.7 | 97 |
GSM687683 | Patient 427 control | 12951.8 | 98 |
GSM687688 | Patient 428 control | 12847.6 | 98 |
GSM687695 | Patient 441 control | 4443.81 | 93 |
GSM687699 | Patient 443 control | 12006.9 | 98 |
GSM687704 | Patient 444 control | 16996.3 | 98 |
GSM687707 | Patient 448 control | 9641.53 | 97 |
GSM687712 | Patient 449 control | 10140.6 | 97 |
GSM687719 | Patient 450 control | 11407.1 | 98 |
GSM687724 | Patient 451 control | 10362.8 | 97 |
GSM687728 | Patient 452 control | 7555.15 | 96 |
GSM687646 | Patient 401 treated 24h | 11968.4 | 98 |
GSM687649 | Patient 402 treated 24h | 9489.14 | 97 |
GSM687665 | Patient 411 treated 24h | 10257 | 97 |
GSM687651 | Patient 402 treated 4 weeks | 9796.28 | 97 |
GSM687667 | Patient 411 treated 4 weeks | 8347.55 | 96 |
GSM687670 | Patient 422 treated 24h | 10806.9 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 8458.88 | 96 |
GSM687654 | Patient 403 treated 24h | 11445.4 | 97 |
GSM687675 | Patient 424 treated 24h | 10225.1 | 97 |
GSM687685 | Patient 427 treated 24h | 10404.6 | 97 |
GSM687656 | Patient 403 treated 4 weeks | 8833.31 | 97 |
GSM687677 | Patient 424 treated 4 weeks | 13318.2 | 98 |
GSM687687 | Patient 427 treated 4 weeks | 10001.2 | 97 |
GSM687692 | Patient 428 treated 4h | 13552.7 | 98 |
GSM687716 | Patient 449 treated 4h | 10234.3 | 97 |
GSM687722 | Patient 450 treated 4h | 12317.8 | 98 |
GSM687680 | Patient 425 treated 24h | 11402.4 | 98 |
GSM687690 | Patient 428 treated 24h | 16454.3 | 98 |
GSM687700 | Patient 443 treated 24h | 10532.7 | 97 |
GSM687705 | Patient 444 treated 24h | 20972.1 | 99 |
GSM687714 | Patient 449 treated 24h | 9309.46 | 97 |
GSM687721 | Patient 450 treated 24h | 10118.3 | 97 |
GSM687682 | Patient 425 treated 4 weeks | 13517 | 98 |
GSM687694 | Patient 428 treated 4 weeks | 9778.51 | 97 |
GSM687702 | Patient 443 treated 4 weeks | 10885.4 | 97 |
GSM687718 | Patient 449 treated 4 weeks | 12606.6 | 98 |
GSM687723 | Patient 450 treated 4 weeks | 12505.9 | 98 |
GSM687661 | Patient 404 treated 4h | 14570 | 98 |
GSM687710 | Patient 448 treated 4h | 8923.47 | 96 |
GSM687726 | Patient 451 treated 4h | 10019.5 | 97 |
GSM687730 | Patient 452 treated 4h | 8580.87 | 97 |
GSM687660 | Patient 404 treated 24h | 14109.7 | 98 |
GSM687697 | Patient 441 treated 24h | 6404.31 | 95 |
GSM687709 | Patient 448 treated 24h | 9446.47 | 97 |
GSM687725 | Patient 451 treated 24h | 13084.6 | 98 |
GSM687729 | Patient 452 treated 24h | 5311.3 | 94 |
GSM687727 | Patient 451 treated 4 weeks | 11975.7 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 6591.75 | 95 |